YUMUŞAK, N. Et Al. 2019. Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668. EANM 2019 Annual Congress of the European Association of Nuclear Medicine , (BARSELONA, Spain), 689.

YUMUŞAK, N., YİĞİN, A., ATILGAN, H. İ., KALAYCI YİĞİN, A., KOCA, G., YILMAZ, R., ... KORKMAZ, M.(2019). Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668 . EANM 2019 Annual Congress of the European Association of Nuclear Medicine (pp.689). BARSELONA, Spain

YUMUŞAK, NİHAT Et Al. "Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668," EANM 2019 Annual Congress of the European Association of Nuclear Medicine, BARSELONA, Spain, 2019

YUMUŞAK, NİHAT Et Al. "Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668." EANM 2019 Annual Congress of the European Association of Nuclear Medicine , BARSELONA, Spain, pp.689, 2019

YUMUŞAK, N. Et Al. (2019) . "Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668." EANM 2019 Annual Congress of the European Association of Nuclear Medicine , BARSELONA, Spain, p.689.

@conferencepaper{conferencepaper, author={NİHAT YUMUŞAK Et Al. }, title={Role of Syndecan Gene in the Pathogenesis of Liver Damage in radioactive Iodine-131 Therapy EP-0668}, congress name={EANM 2019 Annual Congress of the European Association of Nuclear Medicine}, city={BARSELONA}, country={Spain}, year={2019}, pages={689} }